n18

Creapharm buy funded via internal accruals: Dishman Pharma

last updated on January 19, 2012 at 5:09 pm moneycontrol

Dishman Pharmaceuticals and Chemicals' subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals. In an interview to CNBC-TV18, VVS Murthy, chief financial officer of Dishman Pharma says, it is a small R&D formulation development company. The acquisition, he says, is funded trough internal accruals.

Tags : #

YOU MAY LIKE


03:09 26 May 2012 from Moneycontrol

Jet Air wants to boost income via ancillary activities

Moneycontrol Bureau  After posting a fifth straight quarterly loss in the Jan-March quarter, Jet Airways is trying hard to prune its operating costs and improve sales. This, the airline believes can be achieved by cutting down loss-making...

12:59 26 May 2012 from FirstPost

RBI buys $2bn of govt bonds via OMO

The Reserve Bank of India bought Rs 11194 crore ($2.02 billion) of government bonds through open market operation ( OMO) on Friday, lower than the notified Rs12000 crore.The RBI bought the 9.15 percent bonds maturing in 2024 at Rs 104.73 , yielding...

09:59 26 May 2012 from Tech2

Facebook rumoured to buy Opera and launch browser

It seems like we have more browser wars to look forward to. While Yahoo!'s added their own browser, Axis, to the mix, Facebook has been rumoured to be potentially buying Opera Software, the company behind the Opera...

N18 Msg